Key result
Mitochondrial transplantation restores aging cardiac function by suppressing HIF-3α-BNIP3 overactivation and normalising mitophagy flux.
Why the study?
Does mitochondrial transplantation improve cardiac function and restore mitophagy flux in aging hearts?
Does mitochondrial transplantation improve cardiac function and restore mitophagy flux in aging hearts?
p-value: p=<0.05
Mitochondrial transplantation rejuvenates the aging heart by restoring mitophagy flux via the HIF-3α-BNIP3 axis, providing a potential therapeutic strategy for age-related cardiac dysfunction.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“A recent article showed that mitochondrial transfer primarily triggers mitophagy and mitogenesis processes in the cells of organs where mitochondrial transfer was performed. That is, the 'introduced' mitochondria don't function as their own but rather produce a trigger that prompts the host's mitochondria to change their function.”
Mitochondrial transplantation may rejuvenate aged hearts in animal models; leaves open whether this approach translates to human cardiac aging.
Mitochondrial quality control is severely impaired in the aging heart, largely attributed to disrupted mitophagy homeostasis. However, the key molecular drivers remain poorly defined, and the translational value of mitochondria-targeted therapy for cardiac aging is still underexplored. Here, we report prominent mitophagy flux congestion in aged cardiac tissue and confirm that mitochondrial transplantation efficiently rescues impaired mitophagy, ultimately rejuvenating the aging heart. Mechanistically, we identify a novel HIF-3α-BNIP3 signaling axis in the aging heart: HIF-3α, conventionally recognized as a transcriptional repressor, is aberrantly upregulated in senescent cardiomyocytes and directly regulates excessive BNIP3 expression to trigger mitophagy congestion. Notably, we establish an innovative translational strategy that mitochondrial transplantation restrains pathological overactivation of the HIF-3α-BNIP3 axis via improving intracellular ATP homeostasis, thereby reconstructing normal mitophagy flux and reversing cardiac aging. Our findings uncover an unrecognized upstream regulator of age-related mitophagy defects and provide a mitochondrial-based intervention approach for the treatment of aging-associated cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied Cardiac aging. Mitochondrial transplantation vs. PBS (vehicle control) / Doxorubicin-induced aged group was evaluated on Cardiac function (Fractional Shortening, Ejection Fraction) and cellular senescence (p=<0.05). Mitochondrial transplantation rejuvenated the aging heart and restored cardiac function by restraining the pathological overactivation of the HIF-3α-BNIP3 axis and reconstructing normal mitophagy flux.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: